Overview: Toxoplasma IgG TestIntroduction: The Toxoplasma IgG Test detects toxoplasma IgG to confirm past infection, preventing congenital issues. Following 2023 CDC guidelines, it uses immunoassays for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in immunology for pregnant women or immunocompromised patients.
Other Names: Toxoplasma IgG Assay, Anti-Toxoplasma IgG Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: Toxoplasma IgG testing began in the 1960s with congenital infection research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects toxoplasma IgG to confirm past infection, guides preventive measures, and evaluates congenital risk.
Test Parameters: 1. Toxoplasma IgG Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of toxoplasmosis exposure or symptoms.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document toxoplasmosis exposure, pregnancy, or immunocompromised status. Include current medications, especially antiparasitics.
Consent: Written consent required, detailing the tests purpose, congenital infection implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) to detect toxoplasma IgG antibodies. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for congenital risk assessment.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. Cross-reactivity with other antibodies may reduce specificity.
Clinical Significance: Positive IgG confirms past toxoplasma infection, guiding preventive measures in pregnancy. Negative results may require IgM or PCR testing.
Specialist Consultation: Consult an infectious disease specialist or obstetrician for result interpretation and treatment planning.
Additional Supporting Tests: Toxoplasma IgM, PCR, or avidity testing to confirm infection status.
Test Limitations: Non-specific for active infection; clinical correlation is needed. Sample quality affects sensitivity.
References: CDC Toxoplasmosis Guidelines, 2023; Clinical Infectious Diseases, Montoya JG, 2022.
